首页 › 基金 › BVF INC/IL › MLTX
BVF INC/IL 对 MLTX 的持仓历史
MOONLAKE IMMUNOTHERAPEUTICS · 医疗保健
BVF INC/IL 在 Q2 2026 的 13F 申报中披露持有 MLTX(MOONLAKE IMMUNOTHERAPEUTICS)16,001,284 股,市值约 US$311.5M,约占其申报组合的 7.97%,在其申报持仓中市值排名第 4 位。 BVF INC/IL 最近 12 个申报季度中有 12 个季度披露了 MLTX 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
BVF INC/IL 对 MLTX 的持仓演变
BVF INC/IL 于 Q3 2023 首次披露 MLTX 持仓:21,751,284 股(约 US$1.24B)。 该持仓在 Q4 2023 达到峰值 21,751,284 股,市值约 US$1.31B。 在 12 次申报中,BVF INC/IL 0 次增持、2 次减持、9 次保持不变。 最近一期申报(Q2 2026)显示持股 16,001,284 股、市值约 US$311.5M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 21.75M | $1.24B | 新进 |
| Q4 2023 | 21.75M | $1.31B | 持有 |
| Q1 2024 | 21.75M | $1.09B | 持有 |
| Q2 2024 | 21.75M | $956.40M | 持有 |
| Q3 2024 | 21.75M | $1.10B | 持有 |
| Q4 2024 | 19.75M | $1.07B | 减持 |
| Q1 2025 | 19.75M | $771.68M | 持有 |
| Q2 2025 | 19.75M | $932.26M | 持有 |
| Q3 2025 | 19.75M | $141.62M | 持有 |
| Q4 2025 | 19.75M | $260.32M | 持有 |
| Q1 2026 | 16.00M | $298.26M | 减持 |
| Q2 2026 | 16.00M | $311.54M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 MLTX 与 13F 数据
MLTX(MOONLAKE IMMUNOTHERAPEUTICS)属于医疗保健行业。我们追踪的基金中还有 29 只申报持有 MLTX,申报仓位最大的包括:Deep Track Capital, LP (US$136.3M), Cormorant Asset Management, LP (US$62.4M), Logos Global Management LP (US$52.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 MLTX 的基金
- Deep Track Capital, LP 7.00M 股 · $136.27M · Q2 2026
- Cormorant Asset Management, LP 3.21M 股 · $62.41M · Q2 2026
- Logos Global Management LP 2.67M 股 · $52.08M · Q2 2026
- Weiss Asset Management LP 2.58M 股 · $50.27M · Q2 2026
- MPM BioImpact LLC 1.61M 股 · $31.29M · Q2 2026
- Vivo Capital, LLC 1.40M 股 · $27.26M · Q2 2026
- GREAT POINT PARTNERS LLC 855.81K 股 · $16.66M · Q2 2026
- Trails Edge Capital Partners, LP 750.00K 股 · $14.60M · Q2 2026
更多关于 BVF INC/IL
常见问题
How long has BVF INC/IL held MLTX?
BVF INC/IL has disclosed MLTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is BVF INC/IL's current position in MLTX?
As of Q2 2026, BVF INC/IL holds 16.00M shares of MLTX (MOONLAKE IMMUNOTHERAPEUTICS), valued at $311.54M, representing 7.97% of its reported portfolio and ranking #4.
Has BVF INC/IL been buying or selling MLTX?
In the latest 13F filing (Q2 2026), BVF INC/IL held unchanged its position in MLTX. The position peaked in Q4 2023 at 21.75M shares.
Which other funds hold MLTX?
Other major institutional holders of MLTX include Deep Track Capital, LP, Cormorant Asset Management, LP, Logos Global Management LP, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.